These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 6436469)

  • 1. Vasodilatory action of HA1004 [N-(2-guanidinoethyl)-5-isoquinolinesulfonamide], a novel calcium antagonist with no effect on cardiac function.
    Asano T; Hidaka H
    J Pharmacol Exp Ther; 1984 Oct; 231(1):141-5. PubMed ID: 6436469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intracellular Ca++ antagonist, HA1004: pharmacological properties different from those of nicardipine.
    Asano T; Hidaka H
    J Pharmacol Exp Ther; 1985 May; 233(2):454-8. PubMed ID: 3999029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue selectivity of the novel calcium antagonist sesamodil fumarate in isolated smooth muscles and cardiac muscles.
    Nishimura K; Miyawaki N; Yamauchi H; Iso T
    Arzneimittelforschung; 1990 Mar; 40(3):244-8. PubMed ID: 2112000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A post-calcium site of action for HA1004, a novel vasculorelaxant.
    Chiu PJ; Tetzloff G; Sybertz EJ
    Life Sci; 1986 Jul; 39(3):255-61. PubMed ID: 3736325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PN 200-110, a new calcium antagonist: electrophysiological, inotropic, and chronotropic effects on guinea pig myocardial tissue and effects on contraction and calcium uptake of rabbit aorta.
    Hof RP; Scholtysik G; Loutzenhiser R; Vuorela HJ; Neumann P
    J Cardiovasc Pharmacol; 1984; 6(3):399-406. PubMed ID: 6202964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relaxation of vascular smooth muscle by HA-1004, an inhibitor of cyclic nucleotide-dependent protein kinase.
    Ishikawa T; Inagaki M; Watanabe M; Hidaka H
    J Pharmacol Exp Ther; 1985 Nov; 235(2):495-9. PubMed ID: 2997436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vasodilator mechanism of KB-944, a new calcium antagonist.
    Morita T; Kanazawa T; Ito K; Nose T
    Arzneimittelforschung; 1982; 32(9):1043-6. PubMed ID: 6890823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronotropic, inotropic, and vasodilator actions of diltiazem, nifedipine, and verapamil. A comparative study of physiological responses and membrane receptor activity.
    Millard RW; Grupp G; Grupp IL; DiSalvo J; DePover A; Schwartz A
    Circ Res; 1983 Feb; 52(2 Pt 2):I29-39. PubMed ID: 6831652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The methylenedioxyindenes, a novel class of "intracellular calcium antagonists": effects on contractility and on processes involved in regulating intracellular calcium homeostasis.
    Weishaar RE; Quade M; Schenden JA; Kaplan HR
    J Pharmacol Exp Ther; 1983 Dec; 227(3):767-78. PubMed ID: 6655569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of action of a novel antivasospasm drug, HA1077.
    Asano T; Ikegaki I; Satoh S; Suzuki Y; Shibuya M; Takayasu M; Hidaka H
    J Pharmacol Exp Ther; 1987 Jun; 241(3):1033-40. PubMed ID: 3598899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular inhibitory effects of Hyoscyamus niger.
    Khan AU; Gilani AH
    Methods Find Exp Clin Pharmacol; 2008 May; 30(4):295-300. PubMed ID: 18773124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcium channel blocking activity of calycosin, a major active component of Astragali Radix, on rat aorta.
    Wu XL; Wang YY; Cheng J; Zhao YY
    Acta Pharmacol Sin; 2006 Aug; 27(8):1007-12. PubMed ID: 16867251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of calcium antagonists on leukotriene D4-induced contractions of the guinea-pig trachea and lung parenchyma.
    Weichman BM; Muccitelli RM; Tucker SS; Wasserman MA
    J Pharmacol Exp Ther; 1983 May; 225(2):310-5. PubMed ID: 6842394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitor effects of diltiazem, nicardipine, nifedipine and verapamil on the norepinephrine-induced contractions of the canine saphenous vein in calcium-free medium.
    Saïag B; Milon D; Bentue-Ferrer D; Allain H; Rault B; Van den Driessche J
    Res Commun Chem Pathol Pharmacol; 1994 Mar; 83(3):255-69. PubMed ID: 8008975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tiapamil, a new calcium antagonist. 1. Demonstration of calcium antagonistic activity and related studies.
    Eigenmann R; Blaber L; Nakamura K; Thorens S; Haeusler G
    Arzneimittelforschung; 1981; 31(9):1393-401. PubMed ID: 7197945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of naphthylmethyl isoquinoline on the isolated guinea pig myocardium].
    Yang HT; Yang YL
    Yao Xue Xue Bao; 1990; 25(7):485-9. PubMed ID: 2085122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calcium entry blocker activity of cyproheptadine in isolated cardiovascular preparations.
    Winquist RJ; Siegl PK; Baskin EP; Bohn DL; Morgan G; Wallace AA
    J Pharmacol Exp Ther; 1984 Jul; 230(1):103-9. PubMed ID: 6747822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vasodilatory mechanism of levobunolol on vascular smooth muscle cells.
    Dong Y; Ishikawa H; Wu Y; Yoshitomi T
    Exp Eye Res; 2007 Jun; 84(6):1039-46. PubMed ID: 17459374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological in vitro studies of the new 1,4-dihydropyridine calcium antagonist lercanidipine.
    Guarneri L; Angelico P; Ibba M; Poggesi E; Taddei C; Leonardi A; Testa R
    Arzneimittelforschung; 1996 Jan; 46(1):15-24. PubMed ID: 8821512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological basis for the use of Borago officinalis in gastrointestinal, respiratory and cardiovascular disorders.
    Gilani AH; Bashir S; Khan AU
    J Ethnopharmacol; 2007 Dec; 114(3):393-9. PubMed ID: 17900837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.